The global Marine Biotechnology Market is estimated to be valued at US$ 52.9 Mn or Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Marine biotechnology produces pharmaceuticals, biofuels, and nutraceuticals from marine organisms such as bacteria, algae, fungi, marine plants and marine animals. These products offer health benefits in the treatment and prevention of various diseases.
Market key trends:
One of the key trends in the marine biotechnology market is the potential for drug discovery. Marine biotechnology has opened up new opportunities for pharmaceutical companies to develop new medicines for various health conditions. For example, compounds isolated from marine organisms have shown anti-cancer, anti-inflammatory, and antiviral properties. Several clinical trials are underway to test these compounds. Furthermore, with rising ocean temperatures and pollution, marine species are under threat. Bioprospecting of unique marine molecules can help conserve biodiversity. Genome sequencing of marine organisms is also identifying new gene clusters encoding for bioactive natural products. This is expanding the drug discovery pipeline in the marine biotechnology sector.
Read More Insights @ https://www.coherentmarketinsights.com/market-insight/marine-biotechnology-market-6222
SWOT Analysis
Strength: Marine biotechnology has strong potential for drug discovery as marine organisms produce novel bioactive compounds that can be used to develop new drugs. It provides opportunities to harvest commercially important compounds from underutilized marine species.
Weakness: High costs associated with isolating, identifying and testing novel compounds from marine organisms. Long timelines required for drug development and approval limits short term profits.
Opportunity: Untapped potential of various undiscovered marine species offers opportunities for novel discovery. Growing demand for biopharmaceuticals and personal care products drives the scope for new marine-derived products.
Threats: Stringent regulatory approvals pose challenges. Climate change and ocean acidification poses threats to marine biodiversity limiting access to gene pools.
Key Takeaways
The global Marine Biotechnology market is expected to witness high growth, exhibiting CAGR of 4.5% over the forecast period, due to increasing demand for novel bioactive compounds from untapped marine sources for developing new drugs, nutraceuticals and personal care products.
Regional analysis: North America is expected to dominate the global marine biotechnology market over the forecast period owing to strong research collaborations and increasing investments in exploring marine resources. Asia Pacific is expected to exhibit the fastest growth in marine biotechnology market led by countries like Japan, China and India due to growing focus on bioprospecting programs and expanding applications of marine biotechnology.
Key players operating in the Marine Biotechnology market include Abbott laboratories, Johnson & Johnson, Ansell Limited, Becton and Dickinson Company (BD), Boston Scientific Corporation, Medtronic Incorporated, Derma Sciences Incorporated, Kinetic Concepts, Medline Industries Inc., Cardinal Health Incorporated, Minnesota Mining and Manufacturing Company (3M Company), Young Innovations, Transcodent GmbH & Co. KG, Itamar Medical, Baxter International, and SynergEyes, Inc. Strategic collaborations and acquisitions are some key strategies adopted by these players to strengthen their portfolio of marine-derived products and technology offerings.
